TVTX
Travere Therapeutics Inc
NASDAQ: TVTX · HEALTHCARE · BIOTECHNOLOGY
$40.10
-1.93% today
Updated 2026-04-29
Market cap
$3.70B
P/E ratio
—
P/S ratio
7.55x
EPS (TTM)
$-0.57
Dividend yield
—
52W range
$14 – $43
Volume
1.9M
Travere Therapeutics Inc (TVTX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+133.2%
Last 4 quarters
Revenue YoY growth
+73.4%
Most recent quarter
EPS YoY growth
+178.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+8.6%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+17.3%
2025-10-30
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-19 | $0.37 | +1025.0% | $27.87 | $30.39 | +9.0% |
| 2025-10-30 | $0.59 | +303.4% | $29.98 | $35.16 | +17.3% |
| 2025-07-30 | $0.13 | +147.9% | $15.53 | $15.45 | -0.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.04 | $0.37 | +1025.0% | $129.69M | +73.4% |
| 2025-09-30 | $-0.29 | $0.59 | +303.4% | $164.86M | +162.1% |
| 2025-06-30 | $-0.27 | $0.13 | +147.9% | $114.45M | +111.5% |
| 2025-03-31 | $-0.39 | $-0.19 | +51.8% | $81.73M | +97.5% |
| 2024-12-31 | $-0.38 | $-0.47 | -24.1% | $74.79M | +66.0% |
| 2024-09-30 | $-0.68 | $-0.70 | -2.9% | $62.90M | +69.6% |
| 2024-06-30 | $-0.86 | $-0.91 | -5.8% | $54.12M | +68.1% |
| 2024-03-31 | $-0.99 | $-1.76 | -77.8% | $41.37M | — |
| 2023-12-31 | $-1.27 | $-1.18 | +7.1% | $45.06M | — |
| 2023-09-30 | $-0.14 | $-1.17 | -735.7% | $37.09M | — |
| 2023-06-30 | $-1.16 | $-1.13 | +2.6% | $32.20M | — |
Frequently asked questions
Has Travere Therapeutics Inc beaten earnings estimates?
Travere Therapeutics Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +133.2% over the last 3 quarters.
How does TVTX stock react to earnings?
TVTX stock has moved an average of +8.6% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Travere Therapeutics Inc's revenue growth rate?
Travere Therapeutics Inc reported year-over-year revenue growth of +73.4% in its most recent quarter, with EPS growing +178.7% year-over-year.